AC
GILD icon

Apella Capital’s Gilead Sciences GILD Stock Holding History

Apella Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$329K Buy
2,409
+128
+6% +$16.9K ﹤0.01% 566
2026
Q1 		$314K Buy
+2,281
New +$319K ﹤0.01% 541
2021
Q3 		– Sell
-2,940
Closed -$202K – 207
2021
Q2 		$202K Sell
2,940
-772
-21% -$51.5K 0.03% 204
2021
Q1 		$240K Sell
3,712
-1,134
-23% -$73.1K 0.08% 121
2020
Q4 		$282K Hold
4,846
– – 0.1% 112
2020
Q3 		$306K Buy
4,846
+1
+0% +$69 0.12% 100
2020
Q2 		$373K Buy
4,845
+271
+6% +$20.8K 0.17% 87
2020
Q1 		$342K Buy
+4,574
New +$316K 0.2% 82

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Apella Capital's GILD Position: Q2 2026 in Review

Apella Capital increased its Gilead Sciences (GILD) stake by 5.6% in Q2 2026, buying an estimated $16.9K and bringing the position to 2,409 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #566.

Apella Capital first reported a position in GILD in Q1 2020 and has held it in 8 quarters since. The position peaked at $373K in Q2 2020. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Apella Capital held 2,409 shares of Gilead Sciences worth $329K as of Q2 2026.
  • Apella Capital bought 128 Gilead Sciences shares in Q2 2026, an estimated $16.9K.
  • Gilead Sciences made up ﹤0.01% of Apella Capital's portfolio in Q2 2026, its #566 holding.
  • Apella Capital first reported a position in Gilead Sciences in Q1 2020 and has held it in 8 quarters since.
  • Apella Capital's Gilead Sciences position peaked at $373K in Q2 2020.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Apella Capital's 13F filing for Q2 2026, filed 8 Jul 2026.